MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Ownership - Who owns AC Immune SA?

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

Profile

Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
216.29M
P/E Ratio
N/A
Total Cash
127.14M
Projected Growth
N/A
Total Debt
4.92M
Revenue
28.92M
Risk (Beta)
2.27
Dividend Yield
N/A
Total Cash/Share
1.26
Total Debt/Equity
N/A
Revenue/Share
0.36 USD as % of share price

Fundamentals

ACIU
Capitalization
216M
P/E Ratio
N/A
Risk (Beta)
2.27
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
1.26
Total Debt
4.92M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.36%
Revenue
28.9M
ROE
N/A
Book Value
74.7M
P/B Ratio
2.33
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.24M
Current Ratio
1.33
Current Revenue Per Employee
7593.02
Dividends Per Share - Security
N/A
EBITDA
-48.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.62
Shares Held By Institutions
52.9M
Shares Outstanding - Current
101M
Total Liabilities
115M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.370
View a ticker or compare two or three
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACIU showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com